Merck & Company
(MRK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,301,000 | 9,514,000 | 5,085,000 | 17,133,000 | 13,389,000 |
| Depreciation Amortization | 3,372,000 | 2,218,000 | 1,099,000 | 4,499,000 | 3,302,000 |
| Income taxes - deferred | -846,000 | -634,000 | -186,000 | -1,249,000 | -633,000 |
| Accounts receivable | N/A | N/A | N/A | -244,000 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 182,000 | N/A |
| Other Working Capital | -4,657,000 | -5,971,000 | -3,712,000 | -3,667,000 | -1,812,000 |
| Other Operating Activity | 445,000 | 666,000 | 214,000 | 4,814,000 | 3,772,000 |
| Operating Cash Flow | $13,615,000 | $5,793,000 | $2,500,000 | $21,468,000 | $18,018,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 425,000 | -150,000 | -139,000 | -142,000 | 306,000 |
| PPE Investments | -3,079,000 | -2,092,000 | -1,328,000 | -3,372,000 | -2,435,000 |
| Net Acquisitions | N/A | N/A | N/A | -4,093,000 | -4,091,000 |
| Other Investing Activity | 114,000 | -15,000 | -20,000 | -127,000 | -70,000 |
| Investing Cash Flow | $-2,540,000 | $-2,257,000 | $-1,487,000 | $-7,734,000 | $-6,290,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 63,000 | 48,000 | N/A | N/A | N/A |
| Debt Issued | 5,962,000 | N/A | N/A | 3,599,000 | 3,599,000 |
| Debt Repayment | -2,501,000 | -2,500,000 | -2,500,000 | -1,290,000 | -751,000 |
| Common Stock Issued | 45,000 | 31,000 | 19,000 | 177,000 | 165,000 |
| Common Stock Repurchased | -3,832,000 | -2,509,000 | -1,164,000 | -1,306,000 | -817,000 |
| Dividend Paid | -6,158,000 | -4,127,000 | -2,050,000 | -7,840,000 | -5,889,000 |
| Other Financing Activity | -252,000 | -254,000 | -60,000 | -372,000 | -330,000 |
| Financing Cash Flow | $-6,673,000 | $-9,311,000 | $-5,755,000 | $-7,032,000 | $-4,023,000 |
| Exchange Rate Effect | 540,000 | 530,000 | 156,000 | -293,000 | 74,000 |
| Beginning Cash Position | 13,318,000 | 13,318,000 | 13,318,000 | 6,909,000 | 6,909,000 |
| End Cash Position | 18,260,000 | 8,073,000 | 8,732,000 | 13,318,000 | 14,688,000 |
| Net Cash Flow | $4,942,000 | $-5,245,000 | $-4,586,000 | $6,409,000 | $7,779,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,615,000 | 5,793,000 | 2,500,000 | 21,468,000 | 18,018,000 |
| Capital Expenditure | -3,079,000 | -2,092,000 | -1,328,000 | -3,372,000 | -2,435,000 |
| Free Cash Flow | 10,536,000 | 3,701,000 | 1,172,000 | 18,096,000 | 15,583,000 |